Drawing for Serial No. 79020265

USPTO serial 79020265

Serial No. 79020265

Reviewed by CopyMark Law Group

Reg. 3223297Status 706Renewal
Filing date
Status date
Registration date
Mar 27, 2007
Examiner
LAPTER, ALAIN J
Law office
GENERIC WEB UPDATE

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with Serial No. 79020265?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Western medicine and patent medicine, namely, antibiotics, synthetic antibacterial, antiviral, tuberculosis drugs, cardio-cerebrovascular system drugs, cancer drugs, gastrointestinal tract drugs, vitamins, urinary system drugs, coenzyme and biochemical drugs, immunity drugs, antipsychotic drugs, acetaminophen, for the treatment of acute bronchitis, infective endocarditis, cutaneous abscesses, necrotizing subcutaneous infections, lymphadenitis, gonorrhea, mycoplasmal pneumonia, pneumonia, lung abscess, pulmonary tuberculosis, pyogenic ostcomyclitis, septicemia, pyelonephritis, nephritis, urinary infection, phlegmon, peritonsillar abscess, purulent arthritis, pyogenic ostcomyclitis, purulent meningitis, scarlet fever, syphilis, typhoid, influenza, infantile diarrhea, gastric ulcer, gastritis, cardiac arrhythmias, angina pectoris, arteriosclerosis, hyperlipemia, hypertension, cerebral thrombosis, peripheral neuropathies, megaloblastic anemia, iron deficiency anemia, immunosuppressive agent, diabetes mellitus, hepatitis, carcinoma of stomach; biochemical medicine, namely, recombinant human granulocyte-macrophage colony stimulating factor for injection for the prevention and treatment of leukocytopenia caused by chemotherapy or radiotherapy in cancer patients, recombinant human granulocyte colony stimulating factor injection for prevention and treatment of leukopenia caused by chemotherapy or radiotherapy, and neutrupenia following transplantation of bone marrow, recombinant human erythropoetin injection used for anemia cause by renal insufficiency, including patients with chronic renal failure treated with or without hemodialysis, recombinant hepatitis B surface antigen vaccines to get rid of the contamination of viruses contained in human blood; tonics in the nature of medicine, for the treatment of acute bronchitis, infective endocarditis, cutaneous abscesses, necrotizing subcutaneous infections, lymphadenitis, gonorrhea, mycoplasmal pneumonia, pneumonia, lung abscess, pulmonary tuberculosis, pyogenic ostcomyclitis, septicemia, pyelonephritis, nephritis, urinary infection, phlegmon, peritonsillar abscess, purulent arthritis, pyogenic ostcomyclitis, purulent meningitis, scarlet fever, syphilis, typhoid, influenza, infantile diarrhea, gastric ulcer, gastritis, cardiac arrhythmias, angina pectoris, arteriosclerosis, hyperlipemia, hypertension, cerebral thrombosis, peripheral neuropathies, megaloblastic anemia, iron deficiency anemia, immunosuppressive agent, diabetes mellitus, hepatitis, carcinoma of stomach; dietetic substances adapted for medical use, for the treatment of acute bronchitis, infective endocarditis, cutaneous abscesses, necrotizing subcutaneous infections, lymphadenitis, gonorrhea, mycoplasmal pneumonia, pneumonia, lung abscess, pulmonary tuberculosis, pyogenic ostcomyclitis, septicemia, pyelonephritis, nephritis, urinary infection, phlegmon, peritonsillar abscess, purulent arthritis, pyogenic ostcomyclitis, purulent meningitis, scarlet fever, syphilis, typhoid, influenza, infantile diarrhea, gastric ulcer, gastritis, cardiac arrhythmias, angina pectoris, arteriosclerosis, hyperlipemia, hypertension, cerebral thrombosis, peripheral neuropathies, megaloblastic anemia, iron deficiency anemia, immunosuppressive agent, diabetes mellitus, hepatitis, carcinoma of stomach; dietetic foods adapted for medical purposes; diagnostic preparations for medical purposes preparations for acute bronchitis, infective endocarditis, cutaneous abscesses, necrotizing subcutaneous infections, lymphadenitis, gonorrhea, mycoplasmal pneumonia, pneumonia, lung abscess, pulmonary tuberculosis, pyogenic ostcomyclitis, septicemia, pyelonephritis, nephritis, urinary infection, phlegmon, peritonsillar abscess, purulent arthritis, pyogenic ostcomyclitis, purulent meningitis, scarlet fever, syphilis, typhoid, influenza, infantile diarrhea, gastric ulcer, gastritis, cardiac arrhythmias, angina pectoris, arteriosclerosis, hyperlipemia, hypertension, cerebral thrombosis, peripheral neuropathies, megaloblastic anemia, iron deficiency anemia, immunosuppressive agent, diabetes mellitus, hepatitis, carcinoma of stomach; fodder additives for medical purposes; nutritional additives for medical purposes; baby food; medical kits, comprising of antibiotics, synthetic antibacterial, antiviral, tuberculosis drugs, cardio-cerebrovascular system drugs, cancer drugs, gastrointestinal tract drugs, vitamins, urinary system drugs, coenzyme and biochemical drugs, immunity drugs, antipsychotic drugs, acetaminophen; all kinds of pills all included in this class, in the nature of antibiotics, synthetic antibacterial, antiviral, tuberculosis drugs, cardio-cerebrovascular system drugs, cancer drugs, gastrointestinal tract drugs, vitamins, urinary system drugs, coenzyme and biochemical drugs, immunity drugs, antipsychotic drugs, acetaminophen; insecticides; germicides; herbicides; agrochemical herbicides; gelatin for medical purposes; pectin containing preparations for pharmaceutical purposes, namely, antibiotics, synthetic antibacterial, antiviral, tuberculosis drugs, cardio-cerebrovascular system drugs, cancer drugs, gastrointestinal tract drugs, vitamins, urinary system drugs, coenzyme and biochemical drugs, immunity drugs, antipsychotic drugs, acetaminophen, for the treatment of acute bronchitis, infective endocarditis, cutaneous abscesses, necrotizing subcutaneous infections, lymphadenitis, gonorrhea, mycoplasmal pneumonia, pneumonia, lung abscess, pulmonary tuberculosis, pyogenic ostcomyclitis, septicemia, pyelonephritis, nephritis, urinary infection, phlegmon, peritonsillar abscess, purulent arthritis, pyogenic ostcomyclitis, purulent meningitis, scarlet fever, syphilis, typhoid, influenza, infantile diarrhea, gastric ulcer, gastritis, cardiac arrhythmias, angina pectoris, arteriosclerosis, hyperlipemia, hypertension, cerebral thrombosis, peripheral neuropathies, megaloblastic anemia, iron deficiency anemia, immunosuppressive agent, diabetes mellitus, hepatitis, carcinoma of stomach; veterinary medicine, namely, blood serum for veterinary purpose, vaccines for veterinary purpose, diagnosticum for veterinary purpose, chemical material medicine for veterinary purpose, chemical preparations for veterinary purpose, antibiotics for veterinary purpose, biomedicine for veterinary purpose, radioactivity drug for veterinary purpose; medicine, namely, antibiotics, synthetic antibacterial, antiviral, tuberculosis drugs, cardio-cerebrovascular system drugs, cancer drugs, gastrointestinal tract drugs, vitamins, urinary system drugs, coenzyme and biochemical drugs, immunity drugs, antipsychotic drugs, acetaminophen, for the treatment of acute bronchitis, infective endocarditis, cutaneous abscesses, necrotizing subcutaneous infections, lymphadenitis, gonorrhea, mycoplasmal pneumonia, pneumonia, lung abscess, pulmonary tuberculosis, pyogenic ostcomyclitis, septicemia, pyelonephritis, nephritis, urinary infection, phlegmon, peritonsillar abscess, purulent arthritis, pyogenic ostcomyclitis, purulent meningitis, scarlet fever, syphilis, typhoid, influenza, infantile diarrhea, gastric ulcer, gastritis, cardiac arrhythmias, angina pectoris, arteriosclerosis, hyperlipemia, hypertension, cerebral thrombosis, peripheral neuropathies, megaloblastic anemia, iron deficiency anemia, immunosuppressive agent, diabetes mellitus, hepatitis, carcinoma of stomach; Chinese medicine material, namely, antibiotics, synthetic antibacterial, antiviral, tuberculosis drugs, cardio-cerebrovascular system drugs, cancer drugs, gastrointestinal tract drugs, vitamins, urinary system drugs, coenzyme and biochemical drugs, immunity drugs, antipsychotic drugs, acetaminophen; medical plasters; sanitary sterilizing preparations; isopropyl alcohol for medical use; glucose tablets used as a dietary supplement; starch for pharmaceutical purposes, namely, antibiotics, synthetic antibacterial, antiviral, tuberculosis drugs, cardio-cerebrovascular system drugs, cancer drugs, gastrointestinal tract drugs, vitamins, urinary system drugs, coenzyme and biochemical drugs, immunity drugs, antipsychotic drugs, acetaminophen, for the treatment of acute bronchitis, infective endocarditis, cutaneous abscesses, necrotizing subcutaneous infections, lymphadenitis, gonorrhea, mycoplasmal pneumonia, pneumonia, lung abscess, pulmonary tuberculosis, pyogenic ostcomyclitis, septicemia, pyelonephritis, nephritis, urinary infection, phlegmon, peritonsillar abscess, purulent arthritis, pyogenic ostcomyclitis, purulent meningitis, scarlet fever, syphilis, typhoid, influenza, infantile diarrhea, gastric ulcer, gastritis, cardiac arrhythmias, angina pectoris, arteriosclerosis, hyperlipemia, hypertension, cerebral thrombosis, peripheral neuropathies, megaloblastic anemia, iron deficiency anemia, immunosuppressive agent, diabetes mellitus, hepatitis, carcinoma of stomach; primary medicine of western medicine, namely, antibiotics, synthetic antibacterial, antiviral, tuberculosis drugs, cardio-cerebrovascular system drugs, cancer drugs, gastrointestinal tract drugs, vitamins, urinary system drugs, coenzyme and biochemical drugs, immunity drugs, antipsychotic drugs, acetaminophen, for the treatment of acute bronchitis, infective endocarditis, cutaneous abscesses, necrotizing subcutaneous infections, lymphadenitis, gonorrhea, mycoplasmal pneumonia, pneumonia, lung abscess, pulmonary tuberculosis, pyogenic ostcomyclitis, septicemia, pyelonephritis, nephritis, urinary infection, phlegmon, peritonsillar abscess, purulent arthritis, pyogenic ostcomyclitis, purulent meningitis, scarlet fever, syphilis, typhoid, influenza, infantile diarrhea, gastric ulcer, gastritis, cardiac arrhythmias, angina pectoris, arteriosclerosis, hyperlipemia, hypertension, cerebral thrombosis, peripheral neuropathies, megaloblastic anemia, iron deficiency anemia, immunosuppressive agent, diabetes mellitus, hepatitis, carcinoma of stomachACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 27, 2026REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
May 15, 2025RNWLINTERNATIONAL REGISTRATION RENEWED—
Jun 11, 2021CHLDCHANGE OF OWNER RECEIVED FROM IB—
Mar 18, 2017NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Mar 18, 201771AGREGISTERED-SEC.71 ACCEPTED—
Mar 17, 2017ES71TEAS SECTION 71 RECEIVED—
Mar 17, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 27, 2016REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Jul 16, 2015RNWLINTERNATIONAL REGISTRATION RENEWED—
Apr 3, 2013NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Apr 3, 201371AGREGISTERED-SEC.71 ACCEPTED—
Apr 3, 2013APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 19, 2013ES71TEAS SECTION 71 RECEIVED—
Mar 19, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 19, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 6, 2008FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 25, 2007FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 25, 2007FIMPFINAL DISPOSITION PROCESSED—
Sep 19, 2007FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 27, 2007R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 9, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 20, 2006NPUBNOTICE OF PUBLICATION—
Nov 20, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 9, 2006ALIEASSIGNED TO LIE—
Nov 7, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 25, 2006ACECAMENDMENT FROM APPLICANT ENTERED—
Sep 15, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 15, 2006MAILPAPER RECEIVED—
Apr 7, 2006RFNTREFUSAL PROCESSED BY IB—
Mar 15, 2006RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 15, 2006RFRRREFUSAL PROCESSED BY MPU—
Mar 10, 2006RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 9, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 6, 2006DOCKASSIGNED TO EXAMINER—
Mar 6, 2006NWAPNEW APPLICATION ENTERED—
Mar 2, 2006REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance